Paper17516620
A pilot study of tumor necrosis factor inhibition in erosive/inflammatory osteoarthritis of the hands.
Magnano MD and 6 others. J Rheumatol, 2007. Cited by 104 papers, by iCite.
Cite this record
ConductScience Library. A pilot study of tumor necrosis factor inhibition in erosive/inflammatory osteoarthritis of the hands. Papers, record 17516620. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/17516620
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- A pilot study of tumor necrosis factor inhibition in erosive/inflammatory osteoarthritis of the hands.
- PubMed
Topics17
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Antibodies, Monoclonal | Major topic |
| Antirheumatic Agents | Major topic |
| Osteoarthritis | Major topic |
| Tumor Necrosis Factor-alpha | Major topic |
| Adalimumab | |
| Aged | |
| Antibodies, Monoclonal, Humanized | |
| Cartilage, Articular | |
| Disability Evaluation | |
| Dose-Response Relationship, Drug | |
| Female | |
| Hand | |
| Humans | |
| Male | |
| Middle Aged | |
| Pilot Projects | |
| Treatment Outcome |
Source PubMed
Grants1
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| 5 M01 RR000070 | NCRR NIH HHS | United States | M01RR000070 | PubMed and NIH |
Source NIH RePORTER
Cited by51
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 104 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 38157375 | Evaluating the potential of Vitamin D and curcumin to alleviate inflammation and mitigate the progression of osteoarthritis through their effects on human chondrocytes: A proof-of-concept investigation. | PLoS One | 2023 | https://conductscience.org/library/papers/38157375 | PubMed |
| 37649531 | Efficacy of tumor necrosis factor inhibitors in hand osteoarthritis: A systematic review and meta-analysis of randomized controlled trials. | Osteoarthr Cartil Open | 2023 | https://conductscience.org/library/papers/37649531 | PubMed |
| 37492583 | Effects of synovial macrophages in osteoarthritis. | Front Immunol | 2023 | https://conductscience.org/library/papers/37492583 | PubMed |
| 37428931 | NOS inhibition reverses TLR2-induced chondrocyte dysfunction and attenuates age-related osteoarthritis. | Proc Natl Acad Sci U S A | 2023 | https://conductscience.org/library/papers/37428931 | PubMed |
| 36937821 | An update on the use of conventional and biological disease-modifying anti-rheumatic drugs in hand osteoarthritis. | Ther Adv Musculoskelet Dis | 2023 | https://conductscience.org/library/papers/36937821 | PubMed |
| 36507254 | A new frontier in temporomandibular joint osteoarthritis treatment: Exosome-based therapeutic strategy. | Front Bioeng Biotechnol | 2022 | https://conductscience.org/library/papers/36507254 | PubMed |
| 35412048 | [The DRFZ-a pioneer in research on the interaction between immune and stromal cells during de- and regeneration of the musculoskeletal system]. | Z Rheumatol | 2022 | https://conductscience.org/library/papers/35412048 | PubMed |
| 35105980 | Erosive hand osteoarthritis: latest findings and outlook. | Nat Rev Rheumatol | 2022 | https://conductscience.org/library/papers/35105980 | PubMed |
| 34667642 | Autologous protein solution: a promising solution for osteoarthritis? | EFORT Open Rev | 2021 | https://conductscience.org/library/papers/34667642 | PubMed |
| 34386509 | Regulation of Tumor Necrosis Factor-α by Peptide Lv in Bone Marrow Macrophages and Synovium. | Front Med (Lausanne) | 2021 | https://conductscience.org/library/papers/34386509 | PubMed |
| 32691066 | A roadmap to target interleukin-6 in osteoarthritis. | Rheumatology (Oxford) | 2020 | https://conductscience.org/library/papers/32691066 | PubMed |
| 31621560 | Innate inflammation and synovial macrophages in osteoarthritis pathophysiology. | Clin Exp Rheumatol | 2019 | https://conductscience.org/library/papers/31621560 | PubMed |
| 30983879 | Exploring the Involvement of NLRP3 and IL-1β in Osteoarthritis of the Hand: Results from a Pilot Study. | Mediators Inflamm | 2019 | https://conductscience.org/library/papers/30983879 | PubMed |
| 30552176 | Phase IIa, placebo-controlled, randomised study of lutikizumab, an anti-interleukin-1α and anti-interleukin-1β dual variable domain immunoglobulin, in patients with erosive hand osteoarthritis. | Ann Rheum Dis | 2019 | https://conductscience.org/library/papers/30552176 | PubMed |
| 29373736 | Metabolomics of osteoarthritis: emerging novel markers and their potential clinical utility. | Rheumatology (Oxford) | 2018 | https://conductscience.org/library/papers/29373736 | PubMed |
| 29123550 | Mesenchymal Stem Cells for Cartilage Regeneration of TMJ Osteoarthritis. | Stem Cells Int | 2017 | https://conductscience.org/library/papers/29123550 | PubMed |
| 27692966 | Erosive osteoarthritis: A systematic analysis of definitions used in the literature. | Semin Arthritis Rheum | 2017 | https://conductscience.org/library/papers/27692966 | PubMed |
| 27539668 | Low-grade inflammation as a key mediator of the pathogenesis of osteoarthritis. | Nat Rev Rheumatol | 2016 | https://conductscience.org/library/papers/27539668 | PubMed |
| 26963090 | A New Application of Parallel Synthesis Strategy for Discovery of Amide-Linked Small Molecules as Potent Chondroprotective Agents in TNF-α-Stimulated Chondrocytes. | PLoS One | 2016 | https://conductscience.org/library/papers/26963090 | PubMed |
| 26713865 | Genome-Wide DNA Methylation Study Identifies Significant Epigenomic Changes in Osteoarthritic Subchondral Bone and Similarity to Overlying Cartilage. | Arthritis Rheumatol | 2016 | https://conductscience.org/library/papers/26713865 | PubMed |
Genes1
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes |
|---|---|---|---|
| TNF | 7124 | PubTator's text mining | https://conductscience.org/library/genes/7124 |
Source NCBI Gene
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- References
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/17516620
GET https://conductscience.org/api/papers/v1/17516620/cited_by?page=2